THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Voltage‐gated ion channels
暂无分享,去创建一个
Christopher Southan | Stephen PH Alexander | Jörg Striessnig | Eamonn Kelly | Neil V Marrion | John A Peters | Elena Faccenda | Simon D Harding | Adam J Pawson | Joanna L Sharman | Jamie A Davies | Stephen P. H. Alexander | C. Southan | N. Marrion | J. Davies | E. Faccenda | S. Harding | J. Sharman | J. A. Peters | E. Kelly | J. Striessnig
[1] B. Chizh,et al. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. , 2009, Drug discovery today.
[2] Simon Markus Beck. Nutzungsherausgabe bei kaufrechtlicher Ersatzlieferung , 2006 .
[3] D. Jenkinson,et al. Potassium channels – multiplicity and challenges , 2006, British journal of pharmacology.
[4] K. Iwata,et al. Potassium channels as a potential therapeutic target for trigeminal neuropathic and inflammatory pain , 2011, Molecular pain.
[5] Dietmar Krautwurst,et al. Synthetic modulators of TRP channel activity. , 2011, Advances in experimental medicine and biology.
[6] S. Olesen,et al. BK channel modulators: a comprehensive overview. , 2008, Current medicinal chemistry.
[7] Gerasimos S Filippatos,et al. Drug-induced long QT syndrome. , 2007, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.
[8] D. Bayliss,et al. International Union of Pharmacology. LV. Nomenclature and Molecular Relationships of Two-P Potassium Channels , 2005, Pharmacological Reviews.
[9] Nobuaki Takahashi,et al. Chemical physiology of oxidative stress-activated TRPM2 and TRPC5 channels. , 2010, Progress in biophysics and molecular biology.
[10] Ayako Matsuyama,et al. Voltage-gated sodium channels and pain-related disorders. , 2016, Clinical science.
[11] W. N. Zagotta,et al. CNG and HCN channels: two peas, one pod. , 2006, Annual review of physiology.
[12] Poul Behrendt. Søren Kierkegaard’s Fortnight , 2004 .
[13] Shoji Hara,et al. A practical synthetic method of Iodoarene difluorides without fluorine gas and mercury salts , 2002 .
[14] P. Bois,et al. Molecular regulation and pharmacology of pacemaker channels. , 2007, Current pharmaceutical design.
[15] Alexander Zholos,et al. Pharmacology of transient receptor potential melastatin channels in the vasculature , 2010, British journal of pharmacology.
[16] Craig Montell,et al. International Union of Pharmacology. XLIII. Compendium of Voltage-Gated Ion Channels: Transient Receptor Potential Channels , 2003, Pharmacological Reviews.
[17] Harry J Witchel,et al. The hERG potassium channel as a therapeutic target , 2007, Expert opinion on therapeutic targets.
[18] M. Stocker. Ca2+-activated K+ channels: molecular determinants and function of the SK family , 2004, Nature Reviews Neuroscience.
[19] A. Wickenden,et al. Kv7 channels as targets for the treatment of pain. , 2009, Current pharmaceutical design.
[20] Stefan Heller,et al. TRP Channel Trafficking -- TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades , 2007 .
[21] D. Vasilyev,et al. Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels and pain. , 2009, Current pharmaceutical design.
[22] Martin Biel,et al. International Union of Pharmacology. LI. Nomenclature and Structure-Function Relationships of Cyclic Nucleotide-Regulated Channels , 2005, Pharmacological Reviews.
[23] K. S. James,et al. Indian Parish Records : A qualitative assessment , 2000 .
[24] Bernd Nilius,et al. Transient receptor potential channelopathies , 2010, Pflügers Archiv - European Journal of Physiology.
[25] Christopher A Ahern,et al. Chemical tools for K(+) channel biology. , 2009, Biochemistry.
[26] Osvaldo Alvarez,et al. Molecular Determinants of BK Channel Functional Diversity and Functioning. , 2017, Physiological reviews.
[27] Charles R Sanders,et al. Regulation of KCNQ/Kv7 family voltage-gated K+ channels by lipids. , 2017, Biochimica et biophysica acta. Biomembranes.
[28] M. Gollasch,et al. Pharmacological Modulation of Diacylglycerol-Sensitive TRPC3/6/7 Channels , 2011, Current pharmaceutical biotechnology.
[29] Louis V. Gerstner. Question time: organizational shake-ups , 2000, UBIQ.
[30] B. Bean. The action potential in mammalian central neurons , 2007, Nature Reviews Neuroscience.
[31] D. Bayliss,et al. Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact. , 2008, Trends in pharmacological sciences.
[32] Jules C Hancox,et al. The hERG potassium channel and hERG screening for drug-induced torsades de pointes. , 2008, Pharmacology & therapeutics.
[33] D. Clapham,et al. An introduction to TRP channels. , 2006, Annual review of physiology.
[34] William A Catterall,et al. The chemical basis for electrical signaling. , 2017, Nature chemical biology.
[35] K. Rhodes,et al. Localization of voltage-gated ion channels in mammalian brain. , 2004, Annual review of physiology.
[36] Rafał Kaczmarek,et al. Quality Assessment of Welded Joints Using TOFD Technique in View of Requirements of Current Standards , 2017 .
[37] Francesco Altomare,et al. POSITIVE OPERATORS AND APPROXIMATION IN FUNCTION SPACES ON COMPLETELY REGULAR SPACES , 2003 .
[38] W. González,et al. Gating, Regulation, and Structure in K2P K+ Channels: In Varietate Concordia? , 2016, Molecular Pharmacology.
[39] Jayprakash Ninu Chaudhari,et al. On Exact Sequence of Semimodules over Semirings , 2013 .
[40] Irina Vetter,et al. The pharmacology of voltage-gated sodium channel activators , 2017, Neuropharmacology.
[41] Marc Fellous,et al. Genetic male infertility and mutation of CATSPER ion channels , 2010, European Journal of Human Genetics.
[42] S. Olesen,et al. K(v)7 channels: function, pharmacology and channel modulators. , 2006, Current topics in medicinal chemistry.
[43] Yuriy Kirichok,et al. Rediscovering sperm ion channels with the patch-clamp technique. , 2011, Molecular human reproduction.
[44] B. Rudy,et al. International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels , 2005, Pharmacological Reviews.
[45] Annalisa Bucchi,et al. Physiology and pharmacology of the cardiac pacemaker ("funny") current. , 2005, Pharmacology & therapeutics.
[46] P. McNaughton,et al. The thermo‐TRP ion channel family: properties and therapeutic implications , 2012, British journal of pharmacology.
[47] Péter Enyedi,et al. Molecular Background of Leak K (cid:1) Currents: Two-Pore Domain Potassium Channels , 2010 .
[48] Michio Inagaki. New Development in Alkali Metal-Graphite Intercalation Compounds , 1995 .
[49] W. Coetzee,et al. KATP Channels in the Cardiovascular System. , 2016, Physiological reviews.
[50] J. A. Peters,et al. Transient receptor potential cation channels in disease. , 2007, Physiological reviews.
[51] Martin Coleman. Martin Coleman replies to “The place of technology education in the National Curriculum” , 1999 .
[52] T. Strassmaier,et al. The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness. , 2006, Current pharmaceutical design.
[53] Bernd Nilius,et al. The vanilloid transient receptor potential channel TRPV4: from structure to disease. , 2010, Progress in biophysics and molecular biology.
[54] L. Salkoff,et al. High-conductance potassium channels of the SLO family , 2006, Nature Reviews Neuroscience.
[55] Alistair Mathie,et al. Therapeutic potential of neuronal two-pore domain potassium-channel modulators. , 2007, Current opinion in investigational drugs.
[56] Mehrdad Payandeh. Grundrechtsschutz im öffentlichen Kommunikationsraum , 2011 .
[57] Bernd Nilius,et al. Pharmacology of Vanilloid Transient Receptor Potential Cation Channels , 2009, Molecular Pharmacology.
[58] D. Jane,et al. Small conductance calcium-activated potassium channels: From structure to function , 2010, Progress in Neurobiology.
[59] D. Zeevi,et al. TRPML and lysosomal function. , 2007, Biochimica et biophysica acta.
[60] L. Runnels,et al. TRPM6 and TRPM7: A Mul-TRP-PLIK-cation of channel functions. , 2011, Current pharmaceutical biotechnology.
[61] David E. Clapham,et al. International Union of Pharmacology. L. Nomenclature and Structure-Function Relationships of CatSper and Two-Pore Channels , 2005, Pharmacological Reviews.
[62] Yuriy Kirichok,et al. The role of Hv1 and CatSper channels in sperm activation , 2010, The Journal of physiology.
[63] David E. Clapham,et al. mTOR Regulates Lysosomal ATP-Sensitive Two-Pore Na+ Channels to Adapt to Metabolic State , 2013, Cell.
[64] Tibor Rohacs,et al. Phosphoinositide regulation of non-canonical transient receptor potential channels. , 2009, Cell calcium.
[65] Henry A. Lester,et al. International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels. , 2003, Pharmacological reviews.
[66] C. Heurteaux,et al. Targeting two‐pore domain K+ channels TREK‐1 and TASK‐3 for the treatment of depression: a new therapeutic concept , 2015, British journal of pharmacology.
[67] Ming Xu,et al. Animal Models in Studying Cerebral Arteriovenous Malformation , 2015, BioMed research international.
[68] Michael A. Rogawski,et al. Molecular targets for antiepileptic drug development , 2011, Neurotherapeutics.
[69] Hiroshi Ueda,et al. TRPM1: a vertebrate TRP channel responsible for retinal ON bipolar function. , 2010, Cell calcium.
[70] Hiroaki Yamamoto,et al. Integrated interpretation of well logs and surface seismic , 2001 .
[71] Bernd Nilius,et al. Permeation and selectivity of TRP channels. , 2006, Annual review of physiology.
[72] O. Pongs,et al. Ancillary subunits associated with voltage-dependent K+ channels. , 2010, Physiological reviews.
[73] K Lawson,et al. Modulation of potassium channels as a therapeutic approach. , 2006, Current pharmaceutical design.
[74] R. Lathe. Phd by thesis , 1988, Nature.
[75] C. Wahl-Schott,et al. Hyperpolarization-activated cation channels: from genes to function. , 2009, Physiological reviews.
[76] Chunlei Cang,et al. The voltage-gated sodium channel TPC1 confers endolysosomal excitability. , 2014, Nature chemical biology.
[77] Bernd Nilius,et al. TRP Channels in Disease , 2005, Science's STKE.
[78] J. González-Ros,et al. Towards understanding the molecular basis of ion channel modulation by lipids: Mechanistic models and current paradigms. , 2017, Biochimica et biophysica acta. Biomembranes.
[79] U Benjamin Kaupp,et al. Cooperative and uncooperative cyclic-nucleotide-gated ion channels. , 2011, Trends in biochemical sciences.
[80] Karol Bal. HEGEL UND POLEN , 2008 .
[81] Michael X. Zhu,et al. TPC Proteins Are Phosphoinositide- Activated Sodium-Selective Ion Channels in Endosomes and Lysosomes , 2012, Cell.
[82] C. Wahl-Schott,et al. HCN channels: Structure, cellular regulation and physiological function , 2009, Cellular and Molecular Life Sciences.
[83] Laurent Sallé,et al. The non-selective monovalent cationic channels TRPM4 and TRPM5. , 2011, Advances in experimental medicine and biology.
[84] Dejian Ren,et al. Calcium signaling through CatSper channels in mammalian fertilization. , 2010, Physiology.
[85] S. Moss,et al. G Protein-Gated Potassium Channels: A Link to Drug Addiction. , 2017, Trends in pharmacological sciences.
[86] Raimund Mannhold,et al. Structure-activity relationships of K(ATP) channel openers. , 2006, Current topics in medicinal chemistry.
[87] W. Martin,et al. AGONISTS AND ANTAGONISTS , 2006 .
[88] Dario DiFrancesco,et al. HCN-related channelopathies , 2010, Pflügers Archiv - European Journal of Physiology.
[89] Naoto Hoshi,et al. Modulation of Kv7 channels and excitability in the brain , 2016, Cellular and Molecular Life Sciences.
[90] Yoshihiro Kubo,et al. International Union of Pharmacology. LIV. Nomenclature and Molecular Relationships of Inwardly Rectifying Potassium Channels , 2005, Pharmacological Reviews.
[91] A. Dubin,et al. HCN channels as targets for drug discovery. , 2009, Combinatorial chemistry & high throughput screening.
[92] Wendy M. Knowlton,et al. TRPM8: from cold to cancer, peppermint to pain. , 2011, Current pharmaceutical biotechnology.
[93] Xibao Liu,et al. Contribution of TRPC1 and Orai1 to Ca(2+) entry activated by store depletion. , 2011, Advances in experimental medicine and biology.
[94] Bernd Nilius,et al. Store-Operated Ca2+ Entry Channels: Still Elusive! , 2004, Science's STKE.
[95] F. Lesage,et al. Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target? , 2016, Journal of medicinal chemistry.
[96] Yi-Ling Cang,et al. On certain univalent functions with missing coefficients , 2013 .
[97] F. Lesage,et al. The family of K2P channels: salient structural and functional properties , 2015, The Journal of physiology.
[98] Bernd Nilius,et al. Vanilloid transient receptor potential cation channels: an overview. , 2008, Current pharmaceutical design.
[99] Philip Kraft,et al. Synthesis and Olfactory Properties of Spirocyclic Georgywood® Analogues , 2006 .
[100] Po-Cheng Chang,et al. SK channels and ventricular arrhythmias in heart failure. , 2015, Trends in cardiovascular medicine.
[101] Jean-Claude Tardif. Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases. , 2008, Drugs of today.
[102] Leonard K. Kaczmarek,et al. International Union of Basic and Clinical Pharmacology. C. Nomenclature and Properties of Calcium-Activated and Sodium-Activated Potassium Channels , 2017, Pharmacological Reviews.
[103] Yi Liu,et al. TRPM8 in health and disease: cold sensing and beyond. , 2011, Advances in experimental medicine and biology.
[104] Pierangelo Geppetti,et al. Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. , 2010, Journal of medicinal chemistry.
[105] R. Aldrich,et al. International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. , 2005, Pharmacological reviews.
[106] Kai-Chien Yang,et al. Mechanisms contributing to myocardial potassium channel diversity, regulation and remodeling. , 2016, Trends in cardiovascular medicine.
[107] C. Bever,et al. Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. , 2006, Pharmacology & therapeutics.
[108] Christopher Southan,et al. The Concise Guide to PHARMACOLOGY 2015/16: Voltage‐gated ion channels , 2015, British journal of pharmacology.
[109] Dario DiFrancesco,et al. Cycling in the Mechanism of Pacemaking Cardiac Pacemaking : Historical Overview and Future Directions , 2010 .
[110] David E. Clapham,et al. International Union of Basic and Clinical Pharmacology. LXXVI. Current Progress in the Mammalian TRP Ion Channel Family , 2010, Pharmacological Reviews.
[111] Susanne Rinné,et al. Stretch-activated potassium currents in the heart: Focus on TREK-1 and arrhythmias. , 2017, Progress in biophysics and molecular biology.
[112] F. Viana,et al. The emerging pharmacology of TRPM8 channels: hidden therapeutic potential underneath a cold surface. , 2011, Current pharmaceutical biotechnology.
[113] M. Islam,et al. TRP channels of islets. , 2011, Advances in experimental medicine and biology.
[114] Koji Nagata,et al. Additional information decreases the estimated entanglement using the Jaynes principle , 2008, 0801.1944.
[115] Hisashi Yamamoto,et al. A New Scandium Complex as an Extremely Active Acylation Catalyst , 1996 .